National Health Investors, Inc. (NHI) At $75.38 Forms Top; 10-15 Associates Increased Procter And Gamble Co (PG) Holding By $788,310

National Health Investors, Inc. (NHI) formed multiple top with $82.16 target or 9.00% above today’s $75.38 share price. National Health Investors, Inc. (NHI) has $3.13 billion valuation. The stock decreased 0.36% or $0.27 during the last trading session, reaching $75.38. About 192,833 shares traded. National Health Investors, Inc. (NYSE:NHI) has risen 15.23% since January 1, 2017 and is uptrending. It has underperformed by 1.47% the S&P500.

10-15 Associates Inc increased Procter And Gamble Co (PG) stake by 6.47% reported in 2017Q3 SEC filing. 10-15 Associates Inc acquired 8,759 shares as Procter And Gamble Co (PG)’s stock declined 5.32%. The 10-15 Associates Inc holds 144,118 shares with $13.11 million value, up from 135,359 last quarter. Procter And Gamble Co now has $233.10B valuation. The stock decreased 0.21% or $0.19 during the last trading session, reaching $91.88. About 4.35 million shares traded. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since January 1, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.12, from 0.94 in 2017Q2. It fall, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Peregrine Asset Advisers owns 3,162 shares. Greatmark Inv invested in 0.62% or 17,944 shares. Oppenheimer owns 175,141 shares for 0.43% of their portfolio. Schroder Investment Management Grp invested in 0.53% or 3.37 million shares. Commonwealth Of Pennsylvania Public School Empls Retrmt Systems holds 0.28% or 207,384 shares in its portfolio. Advisory accumulated 6,523 shares or 0.2% of the stock. Lsv Asset stated it has 0.01% in The Procter & Gamble Company (NYSE:PG). Pictet Asset Mgmt Ltd owns 1.47M shares. Personal Capital Advsr Corporation reported 356,085 shares. Weaver C Barksdale & Assocs Incorporated invested in 0.91% or 8,981 shares. Wealthtrust Axiom Ltd Liability reported 10,049 shares. Violich Incorporated holds 0.28% or 11,315 shares. Autus Asset Mngmt Lc invested in 0.31% or 17,555 shares. Fulton Breakefield Broenniman Lc reported 13,743 shares stake. Linscomb & Williams invested 0.42% in The Procter & Gamble Company (NYSE:PG).

Since August 15, 2017, it had 0 insider purchases, and 19 insider sales for $6.75 million activity. FergusonMchugh MaryLynn had sold 3,490 shares worth $321,221. Pierce Charles E sold $323,891 worth of stock. The insider Abdelfattah Mohamed Samir Abdelrazek sold $77,130. Giovanni Ciserani sold $422,374 worth of The Procter & Gamble Company (NYSE:PG) on Tuesday, August 15. Another trade for 2,893 shares valued at $266,273 was made by Skoufalos Ioannis on Tuesday, August 15. $587,402 worth of The Procter & Gamble Company (NYSE:PG) shares were sold by Taylor David S. On Tuesday, August 15 Moeller Jon R sold $558,042 worth of The Procter & Gamble Company (NYSE:PG) or 6,063 shares.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 1 Sell and 11 Hold. Therefore 50% are positive. Proctor & Gamble had 72 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of The Procter & Gamble Company (NYSE:PG) has “Outperform” rating given on Wednesday, October 26 by CLSA. The firm has “Outperform” rating by Credit Suisse given on Thursday, July 30. The stock has “Buy” rating by Deutsche Bank on Friday, July 31. As per Friday, October 6, the company rating was maintained by RBC Capital Markets. Johnson Rice upgraded The Procter & Gamble Company (NYSE:PG) on Friday, August 26 to “Buy” rating. Morgan Stanley upgraded the shares of PG in report on Tuesday, January 26 to “Overweight” rating. Sterne Agee CRT initiated The Procter & Gamble Company (NYSE:PG) on Tuesday, July 21 with “Neutral” rating. Citigroup maintained The Procter & Gamble Company (NYSE:PG) on Thursday, August 4 with “Buy” rating. The stock of The Procter & Gamble Company (NYSE:PG) has “Neutral” rating given on Wednesday, January 27 by UBS. B. Riley & Co maintained The Procter & Gamble Company (NYSE:PG) on Monday, October 26 with “Neutral” rating.

Among 10 analysts covering National Health Investors (NYSE:NHI), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. National Health Investors had 20 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, September 22, the company rating was upgraded by Zacks. The stock of National Health Investors, Inc. (NYSE:NHI) earned “Hold” rating by Cantor Fitzgerald on Wednesday, November 8. The firm has “Buy” rating given on Thursday, September 3 by Zacks. KeyBanc Capital Markets maintained the stock with “Hold” rating in Tuesday, November 21 report. On Tuesday, December 19 the stock rating was downgraded by KeyBanc Capital Markets to “Sell”. The stock of National Health Investors, Inc. (NYSE:NHI) earned “Hold” rating by BMO Capital Markets on Monday, October 16. The rating was downgraded by Bank of America to “Neutral” on Wednesday, August 12. The firm has “Market Perform” rating by BMO Capital Markets given on Wednesday, August 12. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, November 9. The firm earned “Hold” rating on Monday, October 16 by KeyBanc Capital Markets.

Since August 24, 2017, it had 0 insider buys, and 1 sale for $159,600 activity. Shares for $159,600 were sold by PASCOE KEVIN CARLTON.

Analysts await National Health Investors, Inc. (NYSE:NHI) to report earnings on February, 16. They expect $1.33 earnings per share, up 4.72% or $0.06 from last year’s $1.27 per share. NHI’s profit will be $55.24M for 14.17 P/E if the $1.33 EPS becomes a reality. After $1.37 actual earnings per share reported by National Health Investors, Inc. for the previous quarter, Wall Street now forecasts -2.92% negative EPS growth.